Inventor · disambiguated record
Daulet Kadyl Satpayev
Also filed as: SATPAYEV DAULET · SATPAYEV DAULET KADYL
14 granted patents·8 pending applications·57 citations·filing 2011–2023
91Inventor score
Top patents by PatentIndex Score
22 records- 0197US11559582B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2020·Granted Jan 24, 2023·3 cites·32 claims
- 0293US10894090B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2018·Granted Jan 19, 2021·4 cites·38 claims
- 0393US9314538B2Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2015·Granted Apr 19, 2016·9 cites·33 claims
- 0492US9078931B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2013·Granted Jul 14, 2015·11 cites·8 claims
- 0591US9962454B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2016·Granted May 8, 2018·6 cites·5 claims
- 0690US8637642B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsSATPAYEV DAULET·Filed 2011·Granted Jan 28, 2014·12 cites·15 claims
- 0789US11254744B2Antigen binding constructs to target moleculesIMAGINAB INC·Filed 2016·Granted Feb 22, 2022·5 cites·32 claims
- 0889USRE48389EAntibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2017·Granted Jan 12, 2021·2 cites·110 claims
- 0986US2023346968A1Antibody drug conjugates (adc) that bind to 191p4d12 proteinsAGENSYS INC·Filed 2022·Application pending·0 cites
- 1084US11266745B2Extension sequences for diabodiesIMAGINAB INC·Filed 2018·Granted Mar 8, 2022·3 cites·25 claims
- 1179US11299708B2Methods for selective expansion of γδ T-cell populations and compositions thereofADICET BIO INC·Filed 2017·Granted Apr 12, 2022·2 cites·15 claims
- 1270US12364714B2Methods for selective expansion of gamma delta t-cell populations and compositions thereofADICET THERAPEUTICS INC·Filed 2022·Granted Jul 22, 2025·0 cites·31 claims
- 1364US2022089730A1Antigen binding constructs to target moleculesIMAGINAB INC·Filed 2021·Application pending·0 cites
- 1463US2025345429A1Compositions and methods comprising chimeric adaptor polypeptidesADICET THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1560US2025108069A1Chimeric adaptor polypeptidesADICET THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1655US2023009275A1Methods for expanding gamma delta t-cell populations with multivalent agents and compositions thereofADICET BIO INC·Filed 2020·Application pending·0 cites
- 1753US12371497B2Antigen binding constructs to CD4IMAGINAB INC·Filed 2019·Granted Jul 29, 2025·0 cites·19 claims
- 1852US2022218747A1Methods for selective in vivo expansion of gamma delta t-cell populations and compositions thereofADICET BIO INC·Filed 2019·Application pending·0 cites
- 1950US2021388100A1Compositions and methods regarding engineered and non-engineered gamma delta t-cells for treatment of hematological tumorsADICET BIO INC·Filed 2019·Application pending·0 cites
- 2050US2021388109A1Compositions and methods regarding engineered and non-engineered gamma delta t-cells for treatment of solid tumorsADICET BIO INC·Filed 2019·Application pending·0 cites
- 2139US12221480B2Methods for selective expansion of delta-3 gamma delta T-cell populations and compositions thereofADICET THERAPEUTICS INC·Filed 2018·Granted Feb 11, 2025·0 cites·28 claims
- 2239US11485785B2Antibodies capable of binding HLA-A2/TyrD in an HLA restricted manner and uses thereofADICET BIO INC·Filed 2017·Granted Nov 1, 2022·0 cites·39 claims
Join the waitlist — get patent alerts
Get an alert when Daulet Kadyl Satpayev files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →